Kyeong A So | Gynecologic oncology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Kyeong A So | Gynecologic oncology | Best Researcher Award

Associate Professor, Konkuk University Hospital, South Korea

Dr. Kyeong A So is an Associate Professor in the Department of Obstetrics and Gynecology at Konkuk University Hospital and School of Medicine, Seoul, Korea. With a distinguished career in gynecologic oncology, Dr. So has contributed significantly to the understanding and treatment of gynecologic cancers. Having earned an M.D., a Master’s degree, and a Ph.D. in Medicine from Korea University, Dr. So’s expertise spans clinical practice, research, and education. They have held various clinical and academic roles, including Assistant Professor and Clinical Professor in prominent hospitals. Dr. So is a leading member of numerous professional organizations such as the Korean Society of Gynecologic Oncology and the Korean Gynecologic Oncology Group. Recognized for their work in both research and education, Dr. So continues to make a remarkable impact in the field through pioneering studies and leadership roles.

Profile

Scopus

Education

Dr. Kyeong A So completed their education at Korea University, Seoul, Korea. They began with the Premedical School from 2000-2002, followed by an M.D. from Korea University School of Medicine (2002-2006). This was followed by advanced postgraduate studies, culminating in a Master of Science degree (2007-2009) and a Doctor of Philosophy (Ph.D.) in Medicine (2009-2012) from Korea University Graduate School. This solid educational foundation has equipped Dr. So with a deep understanding of both clinical and research aspects of gynecologic oncology. Their academic path demonstrates a commitment to continuous learning and advancing medical knowledge, particularly in the field of gynecologic cancer treatment and research.

Experience

Dr. Kyeong A So has an extensive career in both clinical and academic settings. After completing their internship at Seoul National University Hospital (2006-2007), Dr. So trained as a resident at Korea University Guro Hospital, specializing in Obstetrics and Gynecology from 2007-2011. Following residency, they completed a fellowship in Gynecologic Oncology at the same hospital from 2011-2014. Dr. So’s academic journey includes roles as a Clinical Professor at Myongji Hospital (2014-2015) and as an Assistant Professor at Cheil General Hospital and Women’s Healthcare Center (2015-2018). In 2019, they joined Konkuk University Hospital as an Assistant Professor and became an Associate Professor in 2022. In these roles, Dr. So has made significant contributions to medical education, research, and patient care in the field of gynecologic oncology.

Awards and Honors

Dr. Kyeong A So has received several awards and honors in recognition of their excellence in the field of gynecologic oncology. In 2010, they were honored with a Certificate of Commendation from Korea University Medical Center. In 2013, Dr. So received the “Best Oral Abstract” award at the 14th Annual Congress of the Asia-Pacific Association for Gynecologic Endoscopy for their groundbreaking research. Their research has also been widely published and cited, further establishing Dr. So as a leading expert in the field. These accolades reflect Dr. So’s commitment to advancing gynecologic oncology, both through clinical practice and innovative research, and underscore their standing as a respected academic and clinician.

Research Focus

Dr. Kyeong A So’s research focuses on advancing the understanding, diagnosis, and treatment of gynecologic cancers, particularly endometrial and ovarian cancers. They have investigated the molecular and clinical aspects of cancer recurrence, treatment efficacy, and fertility preservation in cancer patients. Dr. So’s work on the impact of menopausal status on HPV infection and vaginal dysbiosis has also contributed to the broader understanding of gynecologic health. Their current research efforts include exploring novel treatment regimens such as immunotherapy and personalized medicine. Through collaboration with international researchers and involvement in clinical trials, Dr. So is committed to improving patient outcomes and providing innovative solutions in the treatment of gynecologic cancers. This work has been widely published, with several articles appearing in high-impact journals, and has garnered significant attention in the scientific community.

Publication Top Notes

  1. Surgical staging in early endometrial cancer without intra-uterine manipulator using the da Vinci SP robotic system 🦠🩺
  2. Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment 🔬
  3. Menopausal status induces vaginal dysbiosis in women with human papillomavirus infection 🔬
  4. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial 📊🧬
  5. The Expression and Amplification of HER2 Has a Significant Impact on the Prognosis of Endometrial Carcinoma in Korean Patients 🧪📑

 

 

Alejandra Guillermina Miranda-Díaz | Clinical Research | Women Researcher Award

Posted on by sciencefather

Prof. Dr. Alejandra Guillermina Miranda-Díaz | Clinical Research | Women Researcher Award

Alejandra Guillermina Miranda Díaz is a distinguished Professor and Researcher with extensive experience in the fields of general surgery, pharmacology, and clinical research. Having pursued a lifelong passion for surgery, she became a Medical Surgeon and Partero at the University of Guadalajara, later specializing in General Surgery and obtaining a Master’s in Medical Sciences and a Doctorate in Pharmacology. Her academic journey reflects a commitment to advancing medical research, particularly in inflammatory diseases and oxidative stress. Miranda Díaz has held significant roles in academia, such as coordinating master’s programs in Medical Sciences and mentoring numerous graduate students. Her expertise has led to collaborations with hospitals and medical professionals on various groundbreaking studies. Her research focuses on understanding the mechanisms of inflammation and oxidative stress, contributing significantly to advancements in clinical pharmacology and surgical practice.

Profile

Education 

Alejandra Guillermina Miranda Díaz’s educational background is rich and diverse, rooted in the University of Guadalajara. She began her academic journey with a Bachelor’s degree in Medicine (1971–1977), followed by an advanced specialization in General Surgery (1983). Driven by a deep interest in medical research, she pursued a Master’s in Medical Sciences (1992), and later, a Doctorate in Pharmacology (2003), solidifying her status as an expert in the field. These academic milestones, supported by a strong foundation in clinical surgery, enabled her to bridge the gap between practical medical procedures and theoretical scientific exploration. Throughout her career, she has been dedicated to applying her educational experience to improve medical knowledge, train future professionals, and contribute to groundbreaking research in fields such as inflammation, oxidative stress, and pharmacology.

Experience 

Alejandra Guillermina Miranda Díaz has dedicated over 40 years to both clinical practice and academic instruction. She began her career as a General Surgeon in the IMSS (Mexican Social Security Institute) in 1983, advancing through various leadership roles such as the Coordinator of the Laparoscopic Surgery Program and Sub-Director of the Medical Morning Shift at Hospital General Regional No. 45. In 2001, she transitioned to academia, becoming a Professor and Researcher in the Department of Physiology at the University of Guadalajara’s Center for Health Sciences. Her role as the Coordinator for various Master’s and Doctorate programs in Medical Sciences allowed her to shape the careers of numerous students. Her expertise has earned her a prominent place in the field, with notable distinctions such as membership in multiple medical associations and the System of National Researchers (SNI), where she holds the level II status until 2026.

Research Focus 

Alejandra Guillermina Miranda Díaz’s research primarily focuses on the role of inflammation and oxidative stress in various diseases, particularly in nephrology and metabolic disorders. Her research examines the complex mechanisms of these processes in conditions such as lupus nephritis, diabetes, and obesity. By studying toll-like receptors (TLRs) such as TLR7 and TLR9, Miranda Díaz explores how these receptors influence disease progression and contribute to inflammatory responses. Her work is pivotal in understanding the broader implications of oxidative stress and inflammation, offering potential therapeutic targets for chronic diseases. Currently, her research includes investigating how inflammation and oxidative stress affect renal function in lupus nephritis and exploring their potential links to metabolic syndrome and obesity. Her work fosters collaboration between medical institutions and researchers, aiming to improve patient care and medical treatment strategies through evidence-based scientific discoveries.

Publication Top Notes

  • The Role of TLRs in Obesity and Its Related Metabolic Disorders 🧬
  • The Expression of Toll-like Receptors (TLR7 and TLR9) in Class III and Class IV of Recently Diagnosed Lupus Nephritis with 12-Month Follow-Up 🧪
  • The Sigma-1 Receptor Exacerbates Cardiac Dysfunction Induced by Obstructive Nephropathy: A Role for Sexual Dimorphism 💖
  • Clinical Impact Using Low Dose Mycophenolate Mofetil with Tacrolimus on Acute Rejection, Infectious Diseases, and Non-Infectious Complications in Renal Transplant: A Single Hospital Experience in Mexico 🏥
  • The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients 🌱
  • Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson’s Disease 🧠
  • The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases ⚖️
  • The Effect of Visceral Abdominal Fat Volume on Oxidative Stress and Proinflammatory Cytokines in Subjects with Normal Weight, Overweight, and Obesity 🏃‍♀️

 

 

Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Dr. Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Associate scientest, King Faisal specialist hospital and research center, Saudi Arabia

Dr. Wijdan Al-Ahmadi is a seasoned researcher with over 20 years of experience in biomedicine, focusing on cancer biology, immunology, and disease mechanisms. Based in Riyadh, Saudi Arabia, she is a key member of the Molecular Biomedicine Research Department at King Faisal Specialist Hospital and Research Center. Her work spans diverse fields, including inflammatory diseases and cardiovascular research. Notably, in 2023, she contributed to a groundbreaking experiment aboard the International Space Station (ISS), highlighting her ability to conduct research in extreme environments. Dr. Al-Ahmadi has demonstrated leadership through her work as an educator, mentoring students at various academic levels. Her contributions continue to push the boundaries of biomedicine, paving the way for new therapeutic strategies and personalized medicine approaches.

Profile

Education

Dr. Wijdan Al-Ahmadi holds a Ph.D. in Bioscience from Cardiff University (2015–2019), where she focused on cancer and immunology research. She also earned a B.Sc. in Biochemistry from King Saud University (1994–1998). Her academic journey has equipped her with advanced expertise in molecular biology, cancer research, and biomedical sciences. Dr. Al-Ahmadi’s educational foundation is complemented by her extensive hands-on experience in laboratory settings, which has enabled her to contribute to numerous pioneering studies. Through her formal education and continuous professional development, she has maintained a passion for unraveling disease mechanisms and enhancing health outcomes through scientific innovation.

Experience

Dr. Al-Ahmadi’s career spans over two decades in the field of biomedicine. She currently serves as an Associate Scientist at King Faisal Specialist Hospital and Research Center in Riyadh, where she leads advanced research projects in cancer biology and immunology. Prior to this, she was a Post-doctoral Fellow (2020–2023), focusing on cancer and inflammatory disease mechanisms. Dr. Al-Ahmadi’s experience includes roles as a Research Assistant (2007–2015) and a Research Technician (2002–2006), where she was deeply involved in cancer research and molecular biology assays. She has also mentored Ph.D., master’s, and undergraduate students throughout her career. Her research has had significant impact both in clinical settings and in experimental fields, including innovative studies aboard the ISS in 2023, demonstrating her versatility in different research environments.

Research Focus

Dr. Wijdan Al-Ahmadi’s research is focused on understanding the underlying mechanisms of diseases, particularly cancer, inflammatory disorders, and cardiovascular diseases. She is dedicated to uncovering how specific genetic mutations and signaling pathways contribute to disease progression, aiming to identify novel therapeutic targets for better patient outcomes. Dr. Al-Ahmadi’s work in space science is also notable, having contributed to microgravity research aboard the ISS, exploring how human physiology and disease processes respond in space. Her findings not only have applications for space health but also provide critical insights that can benefit human health on Earth. She is driven by the potential of personalized medicine and therapeutic interventions that address the root causes of disease.

Publication Top Notes

  1. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation. 🧬🔬
  2. Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high-fat diet. 🥗🧪
  3. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. 🧑‍🔬🦠
  4. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. 🧬💡
  5. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. 🔬💥
  6. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. 🧬📊
  7. Cloning-free regulated monitoring of reporter and gene expression. 🧬🧑‍🔬
  8. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. 🔬🧑‍🔬
  9. Bioinformatics and experimental derivation of an efficient hybrid 3′ untranslated region and use in expression active linear DNA with minimum poly(A) region. 💻🧬
  10. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. 🧪💉

 

 

 

Assoc. Prof. Dr. Gayatri Athalye-Jape | Gut Microbiome | Women Researcher Award

Posted on by sciencefatherLeave a Comment on Assoc. Prof. Dr. Gayatri Athalye-Jape | Gut Microbiome | Women Researcher Award

Assoc. Prof. Dr. Gayatri Athalye-Jape | Gut Microbiome | Women Researcher Award

Consultant neonatal paediatrician, King Edward Memorial Hospital, Australia

Dr. Gayatri Kedar Jape is a distinguished consultant neonatal paediatrician at King Edward Memorial Hospital for Women in Perth, Australia. With extensive expertise in neonatology and paediatrics, her focus encompasses the long-term neurodevelopmental follow-up of preterm infants, gut microbiota-brain axis, probiotics in preterm care, and clinical leadership. She holds several academic titles, including Clinical Associate Professor at the University of Western Australia (UWA) and has been a vital contributor to research on neonatal care and developmental outcomes. Dr. Jape’s leadership roles span various esteemed committees, including the Perinatal Society of Australia and New Zealand, the Global Newborn Society, and the WA Neonatal Network. She has a passion for enhancing staff wellbeing and communication within healthcare settings. Through numerous peer-reviewed publications, clinical trials, and academic mentorship, Dr. Jape has made significant contributions to neonatal health research and education.

Profile

Orcid

Education

Dr. Gayatri Kedar Jape completed her MBBS from the University of Mumbai with honors in 2002. She then pursued her MD in Paediatrics at the same institution, graduating with distinction in 2007. She further expanded her medical knowledge by completing a Fellowship from the Royal Australasian College of Physicians in 2013. Dr. Jape’s academic achievements include certifications in Clinician Performed Ultrasound (2019), a Graduate Certificate in Autism Diagnosis (UWA, 2019), and a Graduate Certificate in Clinical Leadership from UC Davis (2020). Her dedication to advancing neonatal care culminated in a PhD from the University of Western Australia in 2022. Throughout her career, Dr. Jape has continually enriched her expertise, aiming to improve long-term outcomes for preterm infants through her research, clinical care, and teaching roles. Her contributions to the field underscore a strong commitment to integrating innovative solutions into paediatrics.

Experience

Dr. Gayatri Kedar Jape is a consultant neonatal paediatrician at King Edward Memorial Hospital for Women in Perth, where she has been serving since 2015. Her clinical experience spans the complex care of preterm infants, specializing in neonatal nutrition, neurodevelopmental outcomes, and follow-up care. She is also the Clinical Lead of the Neonatal Follow-Up Program at KEMH, focusing on long-term neurodevelopment in preterm infants. Dr. Jape’s leadership extends to high-level roles such as the CAHS Medical Lead for the New Women’s and Babies Hospital Project (2024) and Chair of the PSANZ Long-Term Outcomes Subcommittee (2022–2025). She is deeply engaged in international collaborative efforts, holding executive positions in the Global Newborn Society and the Australian and New Zealand Neonatal Network. In her academic roles at the University of Western Australia, Dr. Jape is shaping the next generation of neonatologists through supervision, lectures, and clinical training.

Research Focus

Dr. Gayatri Kedar Jape’s research focuses on understanding the role of gut microbiota in preterm infants and its link to neurodevelopmental outcomes, particularly autism. She has led clinical trials examining the impact of probiotics on preterm infants, exploring how gut health influences both immediate and long-term health outcomes. Her pioneering studies on probiotics, including the use of single versus multi-strain probiotics, have contributed valuable insights into improving the enteral nutrition of extremely preterm infants. Dr. Jape is also investigating the gut microbiota-brain axis, which has implications for neurodevelopmental disorders. Through her work in neonatal care, she aims to enhance clinical practices and follow-up programs to support the development of preterm infants in the long term. She continues to explore innovative approaches in neonatal nutrition and autism diagnosis, as well as mental health and communication within healthcare teams to foster better staff wellbeing.

Publication Top Notes

  1. Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial – Microorganisms 🧬
  2. Effects of a live versus heat-inactivated probiotic Bifidobacterium spp in preterm infants: a randomised clinical trial – Archives of Disease in Childhood – Fetal and Neonatal Edition 🍼
  3. Benefits of routine probiotic supplementation in preterm infants – Acta Paediatrica, International Journal of Paediatrics 🌱
  4. Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: An updated systematic review with meta-analysis and trial sequential analysis – Journal of Parenteral and Enteral Nutrition 💊
  5. Effect of Probiotic Dose Escalation on Gut Microbiota and Clinical Outcomes in Preterm Infants—A Systematic Review – Children 👶
  6. Growth and neuro-developmental outcomes of probiotic supplemented preterm infants—a systematic review and meta-analysis – European Journal of Clinical Nutrition 📈
  7. Therapeutic hypothermia for neonates with sudden unexpected postnatal collapse – Archives of Disease in Childhood ❄️
  8. Localised chorioangiomatosis associated with fetal right-sided cardiac dilatation – Journal of Paediatrics and Child Health ❤️
  9. Association of gastric residual volumes with necrotising enterocolitis in extremely preterm infants—a case–control study – European Journal of Pediatrics 🏥
  10. Outcomes in extremely low birth weight (≤500 g) preterm infants: A Western Australian experience – Early Human Development 🌍